INVASIVE PROCEDURES IN PATIENTS WITH HAEMOPHILIA ON EMICIZUMAB PROPHYLAXIS: REAL-WORLD CLINICAL EXPERIENCE IN SLOVENIA

被引：0
|
作者：
Rener, K. [1 ]
Pompe, B. [2 ]
Doma, S. Anzej [1 ]
Kotnik, B. Faganel [3 ]
Kitanovski, L. [3 ]
Zupan, I. Preloznik [1 ]
机构：
[1] Univ Med Ctr Ljubljana, Haematol, Ljubljana, Slovenia
[2] Univ Med Ctr Ljubljana, Orthoped Surg, Ljubljana, Slovenia
[3] Univ Med Ctr Ljubljana, Div Paediat, Ljubljana, Slovenia
来源：
HAEMOPHILIA | 2022年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO082
引用
收藏
页码：66 / 66
页数：1
相关论文
共 50 条
  • [1] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A WITH AND WITHOUT INHIBITORS: REAL-WORLD DATA FROM SLOVENIA
    Rener, K.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Fink, M.
    Zupan, I. Preloznik
    HAEMOPHILIA, 2021, 27 : 70 - 70
  • [2] Transitioning patients with severe haemophilia A from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: Real-world clinical experience
    Klamroth, Robert
    Gottstein, Saskia
    HAEMOPHILIA, 2024, 30 (05) : 1247 - 1249
  • [3] Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures
    McCary, Isabella
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Massey, Gita
    Guerrera, Michael F.
    Ballester, Lance
    Raffini, Leslie
    HAEMOPHILIA, 2020, 26 (04) : 631 - 636
  • [4] Real-world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors
    Hassan, Eman
    Jonathan, Lancashire
    Jayashree, Motwani
    HAEMOPHILIA, 2021, 27 (06) : E698 - E703
  • [5] Real-world data of prophylaxis with emicizumab in children and adolescents with severe haemophilia: A single centre experience
    Michalopoulou, A.
    Dettoraki, A.
    Karelioti, H.
    Thymianou, S.
    Papageorgiou, N.
    Stamati, I.
    Saslis, S.
    Kapsimali, Z.
    Pergantou, H.
    HAEMOPHILIA, 2024, 30 : 61 - 61
  • [6] Real-world experience with the use of emicizumab in paediatric haemophilia A patients with and without inhibitors
    Lam, Joyce Ching Mei
    Lim, Chiew Ying
    Kadir, Nur Insyirah Abdul
    HAEMOPHILIA, 2022, 28 : 50 - 51
  • [7] Real-world experience of emicizumab prophylaxis in young children with haemophilia A in China: retrospective data from China
    Huang, Kun
    Liu, Guoqing
    Wu, Runhui
    Chen, Zhenping
    Zhen, Yingzi
    Wu, Xinyi
    HAEMOPHILIA, 2022, 28 : 50 - 50
  • [8] EMICIZUMAB PROPHYLAXIS IN ADULT AND PAEDIATRIC HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS: A SINGLE CENTRE REAL WORLD EXPERIENCE
    Catalano, A.
    Di Gregorio, P.
    Di Cocco, M. L.
    Malizia, R.
    Paolini, F.
    Verna, S.
    HAEMOPHILIA, 2021, 27 : 70 - 70
  • [9] Real-world cost estimates of initiating emicizumab in US patients with haemophilia A
    Samelson-Jones, Benjamin J.
    Guelcher, Christine
    Kuhn, Jan
    Butler, Regina
    Massey, Gita
    Guerrera, Michael F.
    Raffini, Leslie
    HAEMOPHILIA, 2021, 27 (04) : 591 - 598
  • [10] Real-world experience of emicizumab prophylaxis in children with severe haemophilia A: I year follow-up study in egypt
    Sherief, L.
    Hassan, A. S.
    Hamdy, M.
    Darwish, A.
    Nazim, A.
    Hussein, M. A.
    Elgendy, M. R.
    El-assy, O. A.
    HAEMOPHILIA, 2024, 30 : 121 - 121
12345